The average somatic mutation rate of 30 mutations per Mb in three c-Kit mutant melanomas is high compared to other tumors and pre-existing alterations, including activating H-RAS mutations or loss-of-function p16INK4a variants, may diminish c-Kit inhibitor responses [8]. The gene discussed is KIT; the disease is melanoma.